Unique features and clinical importance of acute alloreactive immune responses

Allogeneic stem cell transplantation (allo-SCT) can cure some patients with hematopoietic malignancy, but this relies on the development of a donor T cell alloreactive immune response. T cell activity in the first 2 weeks after allo-SCT is crucial in determining outcome, despite the clinical effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Inman, Charlotte F., Eldershaw, Suzy A., Croudace, Joanne E., Davies, Nathaniel J., Sharma-Oates, Archana, Rai, Tanuja, Pearce, Hayden, Sirovica, Mirjana, Chan, Y.L. Tracey, Verma, Kriti, Zuo, Jianmin, Nagra, Sandeep, Kinsella, Francesca, Nunnick, Jane, Amel-Kashipaz, Rasoul, Craddock, Charles, Malladi, Ram, Moss, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012511/
https://www.ncbi.nlm.nih.gov/pubmed/29769441
http://dx.doi.org/10.1172/jci.insight.97219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012511/
https://www.ncbi.nlm.nih.gov/pubmed/29769441
http://dx.doi.org/10.1172/jci.insight.97219

Ejemplares similares